<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="52020">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01993030</url>
  </required_header>
  <id_info>
    <org_study_id>XY-201301</org_study_id>
    <nct_id>NCT01993030</nct_id>
  </id_info>
  <brief_title>Evaluation of HQ™ Matrix Medical Wound Dressing for Healing of Second Degree Burns and Donor Site Wounds</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhejiang Xingyue Biotechnology Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhejiang Xingyue Biotechnology Co., Ltd.</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the safety and effectiveness of HQ™ Matrix Medical
      Wound Dressing for the use as a dressing for healing of second degree burns and donor site
      wounds.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Wound closure over time</measure>
    <time_frame>21 days post-operation</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Granulation tissue</measure>
    <time_frame>21days post-operation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound infection</measure>
    <time_frame>21days post-operation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain perceived by patient</measure>
    <time_frame>21days post-operation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>VAS scoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exudation</measure>
    <time_frame>21days post-operation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">204</enrollment>
  <condition>Second Degree Burns</condition>
  <condition>Donor Site Wounds</condition>
  <arm_group>
    <arm_group_label>HQ™ Matrix Medical Wound Dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Soho® Silk Wound Dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HQ™ Matrix Medical Wound Dressing</intervention_name>
    <description>Dressing indicated for second degree burns and donor site wounds. Dressing changes every 2-3 days, more frequently if needed</description>
    <arm_group_label>HQ™ Matrix Medical Wound Dressing</arm_group_label>
    <other_name>HQ™ Matrix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Soho® Silk Wound Dressing</intervention_name>
    <description>Dressing indicated for second degree burns and donor site wounds. Dressing changes every 2-3 days, more frequently if needed</description>
    <arm_group_label>Soho® Silk Wound Dressing</arm_group_label>
    <other_name>Soho®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-60 years of age; of either gender and in good general health

          -  Wounds resulting from second degree burns or donor site wounds

          -  Wound size between 20-600 cm²

          -  Participant agrees to participate in follow-up evaluation

          -  Participant must be able to read and understand informed consent, and sign the
             informed consent

        Exclusion Criteria:

          -  Concurrent participation in another clinical trial that involves an investigational
             drug or device that would interfere with this study

          -  Participant is to receive another topical antimicrobial agent other than the study
             dressing

          -  Participant with sensitivity or adverse reactions to silver or zinc

          -  Pregnancy or nursing an infant or child

          -  Immunosuppression

          -  Active or systemic infection

          -  Peripheral vascular occlusive disease

          -  Decision impairment

          -  Connective tissue disease

          -  Participant undergoing active cancer chemotherapy

          -  Chronic steroid use
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jianda Zhou, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Third Xiangya Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jianda Zhou, PhD</last_name>
    <phone>+86-13508493668</phone>
    <email>zhoujianda@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Third Xiangya Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410013</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianda Zhou, PhD</last_name>
      <phone>+86-13508493668</phone>
    </contact>
    <investigator>
      <last_name>Jianda Zhou, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Xiangya Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Qian</last_name>
      <phone>+86-0731-84896038</phone>
    </contact>
    <investigator>
      <last_name>Li Qian</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 19, 2013</lastchanged_date>
  <firstreceived_date>November 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Wound dressing</keyword>
  <keyword>Second Degree Burns</keyword>
  <keyword>Donor Site Wounds</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
